Johnson & Johnson says its bispecific antibody, paired with a Janssen drug, could change treatment for non-small lung cancer ...
Johnson & Johnson closed $25.19 below its 52-week high ($168.85), which the company reached on September 4th.
Republican Mike Johnson won reelection to the House speakership on a first ballot, pushing past GOP hard-right holdouts and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback